LLY SEC Filings
SEC filings for LLY. Annual and quarterly reports, 8-K events,
Form 4 insider filings and 13D/G stake disclosures.
| Form | Filed | Accession |
|---|---|---|
| 8-K | Aug 5, 2026 | 0000059478-26-000077EDGAR |
| 8-K | May 20, 2026 | 0001193125-26-232707EDGAR |
| 8-K | May 7, 2026 | 0000059478-26-000048EDGAR |
| 8-KAIEli Lilly and Company filed an 8-K to furnish its press release announcing financial results for the quarter ended March 31, 2026. | Apr 30, 2026 | 0000059478-26-000043EDGAR |
| 8-KAIEli Lilly and Company filed an 8-K to furnish its press release announcing financial results for the quarter and full year ended December 31, 2025. | Feb 4, 2026 | 0000059478-26-000008EDGAR |
| 8-KAIEli Lilly's Board of Directors elected Dr. Carolyn R. Bertozzi, a Stanford chemistry professor and HHMI Investigator, as a new independent board member effective December 8, 2025. | Nov 21, 2025 | 0000059478-25-000271EDGAR |
| 8-KAIEli Lilly and Company filed an 8-K to furnish its press release announcing financial results for the quarter ended September 30, 2025. | Oct 30, 2025 | 0000059478-25-000251EDGAR |
SEC filings for companies related to LLY
Never miss a LLY filing.
Get an email when LLY files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.
Free foreverNo account requiredOne-click unsubscribe
Source: SEC EDGAR.